- Net Sales: ¥845M
- Operating Income: ¥-55M
- Net Income: ¥-217M
- EPS: ¥-0.66
| Item | Current | Prior | YoY % |
|---|
| Net Sales | ¥845M | ¥624M | +35.4% |
| Cost of Sales | ¥370M | - | - |
| Gross Profit | ¥254M | - | - |
| SG&A Expenses | ¥477M | - | - |
| Operating Income | ¥-55M | ¥-223M | +75.3% |
| Non-operating Income | ¥11M | - | - |
| Non-operating Expenses | ¥5M | - | - |
| Ordinary Income | ¥-65M | ¥-216M | +69.9% |
| Profit Before Tax | ¥-217M | - | - |
| Income Tax Expense | ¥564,000 | - | - |
| Net Income | ¥-217M | - | - |
| Net Income Attributable to Owners | ¥-24M | ¥-156M | +84.6% |
| Total Comprehensive Income | ¥-66M | ¥-245M | +73.1% |
| Interest Expense | ¥113,000 | - | - |
| Basic EPS | ¥-0.66 | ¥-4.31 | +84.7% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|
| Current Assets | ¥1.41B | ¥1.60B | ¥-191M |
| Cash and Deposits | ¥675M | ¥559M | +¥116M |
| Accounts Receivable | ¥595M | ¥789M | ¥-194M |
| Non-current Assets | ¥282M | ¥171M | +¥110M |
| Investment Securities | ¥224M | ¥120M | +¥104M |
| Item | Value |
|---|
| Net Profit Margin | -2.8% |
| Gross Profit Margin | 30.0% |
| Current Ratio | 250.4% |
| Quick Ratio | 250.4% |
| Debt-to-Equity Ratio | 0.50x |
| Interest Coverage Ratio | -486.73x |
| Effective Tax Rate | -0.3% |
| Item | YoY Change |
|---|
| Net Sales YoY Change | +35.6% |
| Item | Value |
|---|
| Shares Outstanding (incl. Treasury) | 36.43M shares |
| Treasury Stock | 4K shares |
| Average Shares Outstanding | 36.43M shares |
| Book Value Per Share | ¥30.97 |
| Item | Amount |
|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Segment | Revenue | Operating Income |
|---|
| Sharing | ¥8M | ¥-24M |
| Item | Forecast |
|---|
| Net Sales Forecast | ¥3.75B |
| Operating Income Forecast | ¥142M |
| Ordinary Income Forecast | ¥141M |
| Net Income Attributable to Owners Forecast | ¥54M |
| Basic EPS Forecast | ¥1.48 |
| Dividend Per Share Forecast | ¥0.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
Verdict: FY2026 Q1 was a top-line beat but a loss-making quarter, with operating losses persisting despite strong revenue growth. Revenue rose 35.6% YoY to 8.45, demonstrating solid demand and/or successful monetization initiatives. Gross profit is reported at 2.54, implying a gross margin of 30.0%, but this conflicts arithmetically with the reported cost of sales; we proceed using the disclosed gross profit and margin. SG&A expenses were 4.77, equating to a high 56.4% of revenue, which overwhelmed gross profit and drove operating income to -0.55 (operating margin roughly -6.5%). Non-operating income was modest at 0.11 (mainly investment securities gains), partially offset by 0.05 in non-operating expenses. Ordinary income is reported at -0.65; the bridge from operating to ordinary appears directionally consistent but the absolute values suggest data gaps. Profit before tax of -2.17 implies the presence of unreported extraordinary losses (approximately -1.5) not itemized in the dataset. Net income was -0.24 (EPS -0.66 yen), indicating that bottom-line losses narrowed significantly relative to the PBT gap, likely due to minority interests or adjustments. Liquidity remains strong with current assets of 14.10, cash and deposits of 6.75, and a current ratio of 250.4%. Leverage is modest with total liabilities of 5.63 against total equity of 11.28, giving balance sheet resilience (equity ratio roughly 66.7% by calculation). Working capital is ample at 8.47, supported by sizable receivables (5.95) and cash. Capital efficiency is weak, with reported ROIC of -9.6% and DuPont ROE of -2.1% driven by negative net margin. Cash flow information is unreported, limiting earnings quality assessment; OCF/NI cannot be gauged. Forward-looking, the key to breakeven is SG&A control and/or gross margin expansion; the Q1 revenue base provides a platform, but the cost structure remains heavy. The quarter also displays income statement inconsistencies (gross profit and operating bridge) that likely stem from unreported line items; conclusions are therefore tentative and focus on direction rather than precise magnitudes.
ROE decomposition indicates: Net Profit Margin at -2.8%, Asset Turnover at 0.50x, and Financial Leverage at 1.50x, resulting in a calculated ROE of -2.1%. The dominant driver of ROE weakness is the negative margin, as asset turnover is mid-range for a digital/services business and leverage is conservative. Operating margin pressure stems from elevated SG&A at 56.4% of revenue versus a 30.0% gross margin, yielding negative operating leverage. The reported operating income (-0.55) is substantially better than the simple GP-SG&A arithmetic, implying other operating line items (unreported) supported results; this raises uncertainty around sustainability. There is no evidence that asset turnover materially deteriorated this quarter; balance sheet size (assets 16.91) versus sales suggests limited efficiency change. Non-operating contributions were minor (net +0.06), and extraordinary items likely weighed on PBT (-2.17), indicating one-time headwinds may have amplified losses. Given revenue growth of +35.6% YoY, scale benefits could eventually improve margins if SG&A growth moderates; however, Q1 shows SG&A density still too high. Monitoring whether SG&A growth outpaces revenue is critical; at 56.4% of sales, even modest deleveraging could swing operating income. Overall, profitability hinges on cost discipline and improving gross margin mix; current negative net margin is not yet consistent with a sustainable turnaround.
Top-line growth of +35.6% YoY to 8.45 is a clear positive, suggesting traction in core offerings. The quality of growth is uncertain due to the gross profit inconsistency; we rely on the disclosed 30.0% GPM. Operating leverage did not materialize: SG&A at 4.77 absorbed gains, keeping operating margin at approximately -6.5%. Non-operating gains (0.11) were small and investment-related; they should not be considered a durable growth driver. Absent segment disclosure, the sustainability of demand is inferred from the magnitude of growth; however, receivables at 5.95 (70% of quarterly sales) imply elongated collection cycles that need watching. The path to profitability likely requires either price/mix improvements lifting gross margin above 35% or SG&A/sales moving below 45–50%. Without OCF data, we cannot validate that revenue growth is cash-generative; this is a key limitation. Short-term outlook: continued revenue growth could narrow losses if management tightens discretionary spend and reduces customer acquisition costs. Medium-term, accumulated deficits (-8.61 retained earnings) underscore the need for sustained operating improvements before resuming dividends or pursuing aggressive investment.
Liquidity is strong: current assets 14.10 vs current liabilities 5.63 give a current ratio of 250.4% and quick ratio equivalent, comfortably above benchmarks. Cash and deposits of 6.75 cover short-term loans (1.20) by 5.6x, indicating low refinancing risk. Solvency is solid with total equity 11.28 against total liabilities 5.63; calculated equity ratio is approximately 66.7%. The reported D/E of 0.50x is conservative; interest-bearing debt disclosure is incomplete, but short-term loans are modest. No warning for Current Ratio (<1.0) or D/E (>2.0) is triggered. Maturity mismatch risk appears low: all liabilities are current, but they are well covered by cash and receivables. Noncurrent liabilities are unreported; we assume minimal based on total liabilities equaling current liabilities. Investment securities of 2.24 introduce market/value volatility on the balance sheet but do not impair liquidity. Retained earnings are negative (-8.61), indicating cumulative losses and potential constraints on future distributions.
Operating cash flow is unreported; therefore, OCF/Net Income and free cash flow cannot be calculated. As such, we cannot assess whether earnings (albeit negative) align with cash generation; OCF/NI < 0.8 cannot be evaluated. Working capital indicators suggest reliance on receivables (5.95) to fund operations while payables are 1.84; net working capital intensity is high, which could weigh on OCF if collections slow. No explicit signs of working capital manipulation can be identified without cash flow detail; however, the high receivables-to-sales ratio warrants monitoring. Capex is unreported, so FCF coverage for any dividend or growth investment cannot be assessed. Given adequate cash (6.75) and limited debt (1.20 ST), near-term liquidity is fine, but sustainability of cash without OCF visibility is unclear.
Dividend data are unreported, and retained earnings are negative (-8.61), implying a low likelihood of near-term cash dividends under JGAAP convention unless sourced from capital surplus and allowed by policy. With FCF unreported, payout capacity cannot be verified. Balance sheet liquidity is strong, but profit generation is currently negative, and ROIC is -9.6%, both inconsistent with sustainable shareholder distributions. Policy outlook likely prioritizes reinvestment and earnings recovery over payouts. Until operating income turns sustainably positive and OCF covers any prospective dividends, dividend visibility remains low.
Business Risks:
- Margin pressure from high SG&A (56.4% of revenue) leading to continued operating losses
- Revenue quality uncertainty given high receivables relative to quarterly sales (collection risk)
- Dependence on non-operating gains (0.11 from investment securities) that are volatile and non-recurring
- Potential extraordinary losses (implied by PBT -2.17) impacting earnings stability
- Competitive intensity in digital/IT/media/HR services, requiring sustained marketing and product investment
Financial Risks:
- Negative ROIC (-9.6%) indicating value-destructive investment at current returns
- Accumulated deficits (-8.61 retained earnings) limiting financial flexibility for distributions
- Market value risk on investment securities (2.24) affecting equity through OCI or PL depending on classification
- Receivables concentration elevating working capital and cash conversion risk
Key Concerns:
- Data inconsistencies between gross profit, SG&A, operating income, and ordinary income suggest unreported line items that hinder precise analysis
- Lack of cash flow disclosure prevents assessment of earnings quality (OCF/NI) and FCF sustainability
- Extraordinary items appear material this quarter, but details are missing
Key Takeaways:
- Strong revenue growth (+35.6% YoY) but still loss-making at operating and net levels
- Cost structure heavy: SG&A at 56.4% of revenue vs gross margin 30.0%
- Balance sheet robust with current ratio ~250% and equity ratio ~67%
- Capital efficiency weak: ROE -2.1%, ROIC -9.6%
- Non-operating and extraordinary items contributed to volatility; quality of earnings uncertain
- Receivables high relative to sales; watch cash conversion cycle
- Negative retained earnings constrain near-term dividend potential
Metrics to Watch:
- Operating margin progression and SG&A/revenue ratio each quarter
- Gross margin mix and pricing power
- OCF and FCF once disclosed; OCF/NI ratio target >1.0
- DSO trends and receivables balance vs revenue
- Any extraordinary items disclosure and their recurrence
- Cash balance vs short-term loans and any changes in debt structure
Relative Positioning:
Versus small-cap domestic digital/service peers, Globalway shows stronger liquidity and low leverage but weaker profitability and capital efficiency; the growth trajectory is encouraging, yet operating leverage has not materialized, keeping it behind peers that have already achieved breakeven and positive OCF.
This analysis was auto-generated by AI. Please note the following:
- No Guarantee of Accuracy: The accuracy and completeness of this analysis are not guaranteed. For accurate financial data, please refer to the original disclosure documents published on TDnet or other official sources
- Not Investment Advice: This analysis is for general informational purposes only and does not constitute investment advice under applicable securities laws. It is not a recommendation to buy or sell any specific securities
- At Your Own Risk: Investment decisions should be made at your own discretion and risk. We assume no liability for any losses incurred based on this analysis